Skip to main content

Idiopathic Pulmonary Fibrosis

Advances in Diagnostic Tools and Disease Management

  • Book
  • © 2016

Overview

  • Introducing new developments such as serum makers that are highly specific to IPF, the establishment of systematic diagnosis imaging and antifibrotic agent

  • Each chapter addresses key issues under discussion and provides perspective on future developments in the field

  • Valuable source for beginning learners to physicians, instructors and researchers whose work involves IIPs

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

  1. Definition, Epidemiology, and Pathogenesis

  2. Diagnosis

  3. Management and Prognosis

  4. Topics

Keywords

About this book

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

Editors and Affiliations

  • Department of Respiratory Medicine, Tokyo Medical University, Ibaraki Medical Center , Ibaraki, Japan

    Hiroyuki Nakamura

  • Department of Respiratory Medicine , Tokyo Medical University, Ibaraki Medical Center, Ibaraki, Japan

    Kazutetsu Aoshiba

About the editors

Hiroyuki Nakamura, MD, PhD.

Department of Respiratory Medicine,

Tokyo Medical University Ibaraki Medical Center, Japan

Kazutetsu Aoshiba, MD, PhD.

Department of Respiratory Medicine,

Tokyo Medical University Ibaraki Medical Center, Japan

Bibliographic Information

  • Book Title: Idiopathic Pulmonary Fibrosis

  • Book Subtitle: Advances in Diagnostic Tools and Disease Management

  • Editors: Hiroyuki Nakamura, Kazutetsu Aoshiba

  • DOI: https://doi.org/10.1007/978-4-431-55582-7

  • Publisher: Springer Tokyo

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Japan 2016

  • Hardcover ISBN: 978-4-431-55581-0Published: 08 October 2015

  • Softcover ISBN: 978-4-431-56281-8Published: 23 August 2016

  • eBook ISBN: 978-4-431-55582-7Published: 28 September 2015

  • Edition Number: 1

  • Number of Pages: X, 259

  • Topics: Pneumology/Respiratory System, Cytokines and Growth Factors

Publish with us